(888) 645-1617
Drugwatch.com Author

Emily Miller Content Writer

Emily Miller brings a unique perspective and passion to Drugwatch. She was diagnosed with a chronic illness as a child, and as part of her daily routine for more than a decade she unknowingly took some of the same potentially risky drugs she now reports on as a researcher and writer for Drugwatch. Not only has Emily experienced side effects of drugs, but also she has had to grapple with the high cost of "specialty" drugs -- expensive medications that have no generic substitutes -- another topic she covers for Drugwatch. Since joining Drugwatch, Emily has also authored a Children’s Comprehensive Health Guide and pioneered the organization’s research and coverage of vaccines, adding these topics to her ever-evolving knowledge of the health industry.

As a patient herself, Emily understands how it’s easy to assume drugs are safe simply because they are FDA-approved. However, through her personal and professional experiences, she has learned that some drugs can leave patients with life-altering consequences without proper warning — a fact that motivates her to help patients and their families stay informed when it comes to prescription and over-the-counter drugs.

As a content writer and researcher for Drugwatch, Emily is committed to delivering well-researched, accurate and easy-to-understand content that educates, engages and inspires readers. She holds five Health Literacy certificates from the Centers for Disease Control and Prevention, including Health Literacy for Public Health Professionals; Writing for the Public; Creating Easier to Understand Lists, Charts and Graphs; Fundamentals of Communicating Risks; and Using Numbers and Explaining Risks.

Emily began her professional career as a journalist while attending the University of Florida. She worked as an editorial assistant for Miami magazine and as the production assistant at The Brechner Center for Freedom of Information, a unit of the University of Florida College of Journalism and Communications. She also contributed to the campus newspaper, the Independent Florida Alligator.

Emily went on to work as a writer for UF Health News; an editor, producer and anchor for WUFT.org; and a correspondent for The Gainesville Sun. She worked for the Reporters Committee for Freedom of the Press in Washington, D.C., and the San Antonio Express-News in San Antonio, Texas. Her assignments ranged from writing news and feature stories about health topics to covering state and federal court proceedings, lawsuits and the U.S. Supreme Court during the time of the Affordable Care Act decision.

After graduating with a bachelor’s degree in journalism from UF, Emily covered crime, breaking news and local government for the South Florida Sun Sentinel. There, her passion for being an advocate and voice for victims only grew stronger, and in 2017, she joined Drugwatch.


Health & Medical Conditions 9.19.17 Nurse at pharmacy clinic giving flu shot to patient

Survey: More Americans Getting Seasonal Flu Vaccine

Nearly two-thirds of U.S. adults say they get the flu vaccine each year or plan to get one in 2017, according to a July 2017 survey by Harris Poll on...

Learn More
Personal Stories 9.14.17 Picture of Gail deVore, a Type 1 diabetic

The Cost of High Drug Prices: ‘If We Can’t Afford It, We Die’

In her 45 years as a Type 1 diabetic, Gail deVore has seen the price of insulin skyrocket to $350 per bottle. “I remember paying $75 a bottle....

Learn More
Dangerous Prescription Drugs 8.31.17 Delivery drone in warehouse

Pharmacy Floats Drone-Based Delivery Concept for Viagra

A successful trial has given rise to a potential new delivery system for Viagra. An online pharmacy in the UK is planning...

Learn More
Current Litigation & Lawsuit News 8.29.17 lawyer speaking to a jury

Jury Sides with Bayer, J&J in Third Trial over Xarelto Bleeding Risks

Makers of the blood thinner Xarelto are not liable for a Mississippi woman’s severe internal bleeding, a federal jury found...

Learn More
Current Litigation & Lawsuit News 5.26.17

J&J Reaches $33 Million Settlement with States

Pharmaceutical giant Johnson & Johnson will pay $33 million to at least...

Learn More